Business Relations Table - o4.fyi ()

Anmelden Gast|Guest

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

s

p

o

BR-Editor

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol

Bliss Symbol für reply

Domain-Statistiken für "ir.ymabs.com"

19

Business Relations

20

Eindeutige Domains

19

Gefundene Einträge

BR-Relations: 19

From Domain	Role	To Domain	Path	Aktionen
ir.ymabs.com	>>isreferencefrom.png CID: 0	lyo-x.com	/en/publications
ir.ymabs.com	>>isreferencefrom.png CID: 0	marketgenics.co	/reports/radioligand-therapies-rlt-market-76312
ir.ymabs.com	>>isreferencefrom.png CID: 0	kapitalpartner.dk	/en/swedish-firm-with-artificial-heart-rise-144-healthcare-stocks-in-upward-trend/
ir.ymabs.com	>>isreferencefrom.png CID: 0	studyscavenger.com	/bio-spaces-clinical-trial-review-november-11-15/
developers.cloudflare.com	>>isreferencefrom.png CID: 0	ir.ymabs.com	/cdn-cgi/l/email-protection
cloudflare.com	>>isreferencefrom.png CID: 0	ir.ymabs.com	/cdn-cgi/l/email-protection
globenewswire.com	>>isreferencefrom.png CID: 0	ir.ymabs.com	/news-releases/news-release-details/serb-pharmaceuticals-completes-acquisition-y-mabs-therapeutics
linkedin.com	>>isreferencefrom.png CID: 0	ir.ymabs.com	/
ymabs.com	>>isreferencefrom.png CID: 0	ir.ymabs.com	/
ir.ymabs.com	>>isreferencefrom.png CID: 0	danskbiotek.dk	/news/y-mabs-danyelza-naxitamab-gqgk-for-the-treatment-of-high-risk-neuroblastoma-approved-in-china/
ir.ymabs.com	>>isreferencefrom.png CID: 0	openmedscience.com	/unleashing-a-new-era-in-neuroblastoma-treatment-the-promise-of-lutetium-177-dtpa-omburtamab/
ir.ymabs.com	>>isreferencefrom.png CID: 0	radiology.weill.cornell.edu	/research/molecular-imaging-innovations-institute-mi3/sarah-m-cheal-laboratory
ir.ymabs.com	>>isreferencefrom.png CID: 0	imaa-institute.org	/blog/2025-top-global-m-and-a-deals-2/
ir.ymabs.com	>>isreferencefrom.png CID: 0	timmermanreport.com	/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/
ir.ymabs.com	>>isreferencefrom.png CID: 0	labiotech.eu	/interview/radiomedix-radiopharma/
ir.ymabs.com	>>isreferencefrom.png CID: 0	serb.com	/news/serb-pharmaceuticals-agrees-to-acquire-y-mabs-therapeutics/
ir.ymabs.com	>>isreferencefrom.png CID: 0	checkrare.com	/2022-orphan-drugs-pdufa-dates-and-fda-approvals/
ir.ymabs.com	>>isreferencefrom.png CID: 0	investingnews.com	/healthcare-forecast/
ir.ymabs.com	>>isreferencefrom.png CID: 0	fiercebiotech.com	/biotech/fierce-biotech-layoff-tracker-2025